A Master Phase 1/2/3 protocol to investigate the safety, tolerability, and immunogenicity of bivalent BNT162b2 RNA-based vaccine candidate(s) in healthy children
COVID-19 Vaccine Research Study
What is the goal of the study?
The goal of the study is to better understand how well the updated vaccine works in children who have not been previously vaccinated and to see if the number of recommended vaccine doses can potentially be reduced for children under 5 years of age.
Who can participate in the study?
Please contact the study team listed below to learn more.